title: Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients.
authors.affiliation: Service de Médecine Interne.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Dumas
authors.affiliation: Service de Médecine Interne, French Sickle Cell Referral Center, Groupe Hospitalier Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris (APHP), and INSERM-U955, Equipe 2: Transfusion et Maladies du Globule Rouge, Laboratoire d'Excellence, GRex, Institut Mondor, Université Paris-Est Créteil, Créteil, France;
authors.forename: Anoosha
authors.initials: A
authors.lastname: Habibi
authors.affiliation: Service de Réanimation, Centre Hospitalier Régional Universitaire, Lille, France;
authors.forename: Thierry
authors.initials: T
authors.lastname: Onimus
authors.affiliation: Service d'Anesthésie-Réanimation and.
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Merle
authors.affiliation: Service de Réanimation Médicale, Groupe Hospitalier Henri Mondor-Albert Chenevier, APHP, Université Paris-Est Créteil, Créteil, France;
authors.forename: Keyvan
authors.initials: K
authors.lastname: Razazi
authors.affiliation: Service de Réanimation Médicale, Groupe Hospitalier Henri Mondor-Albert Chenevier, APHP, Université Paris-Est Créteil, Créteil, France;
authors.forename: Armand
authors.initials: A
authors.lastname: Mekontso Dessap
authors.affiliation: French Sickle Cell Referral Center, Groupe Hospitalier Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris (APHP), and.
authors.forename: Frederic
authors.initials: F
authors.lastname: Galactéros
authors.affiliation: Service de Médecine Interne.
authors.forename: Marc
authors.initials: M
authors.lastname: Michel
authors.affiliation: INSERM, Unité Mixte de Recherche en Santé 872, Cordeliers Research Center and Service d'Immunologie Biologique, Hôpital Européen Georges Pompidou, APHP, Paris, France; and.
authors.forename: Veronique
authors.initials: V
authors.lastname: Frémeaux Bacchi
authors.affiliation: INSERM-U955, Equipe 2: Transfusion et Maladies du Globule Rouge, Laboratoire d'Excellence, GRex, Institut Mondor, Université Paris-Est Créteil, Créteil, France; Établissement Français du Sang Ile de France, Créteil, France.
authors.forename: France
authors.initials: F
authors.lastname: Noizat Pirenne
authors.affiliation: Service de Médecine Interne, French Sickle Cell Referral Center, Groupe Hospitalier Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris (APHP), and INSERM-U955, Equipe 2: Transfusion et Maladies du Globule Rouge, Laboratoire d'Excellence, GRex, Institut Mondor, Université Paris-Est Créteil, Créteil, France;
authors.forename: Pablo
authors.initials: P
authors.lastname: Bartolucci
mesh_terms: D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000628:therapy*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D016879:Salvage Therapy / Q000379:methods*; D065227:Transfusion Reaction / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab